Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,030,751,525
+$2,866,846,090 QoQ
Shares Held
39,819,151
+156.5% QoQ
Ownership
3.21%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#6
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. GILD ranks #2 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,033,480 | $923,849,108 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,030,751,525 | 39,819,151 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,163,905,435 | 15,526,336 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,912,822,004 | 15,584,341 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,680,504,591 | 15,139,681 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,499,098,536 | 13,521,228 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,134,718,909 | 10,126,898 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,041,740,997 | 11,277,915 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $837,185,649 | 9,985,516 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $690,739,536 | 10,067,622 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $826,257,428 | 11,279,965 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $943,669,357 | 11,648,801 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $776,630,110 | 10,363,359 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $840,836,541 | 10,910,037 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $843,843,138 | 10,170,461 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $848,495,632 | 9,883,467 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $568,634,846 | 9,217,618 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $543,786,818 | 8,797,716 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $457,986,621 | 7,703,728 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $539,326,959 | 7,427,723 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $486,998,523 | 6,972,062 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $452,579,865 | 6,572,464 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $374,055,554 | 5,787,646 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $268,129,758 | 4,602,296 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $269,227,053 | 4,260,596 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $491,606,350 | 6,389,477 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $606,812,409 | 8,116,806 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||